Your browser doesn't support javascript.
Epidemiological characterisation of the first 785 SARS-CoV-2 Omicron variant cases in Denmark, December 2021.
Espenhain, Laura; Funk, Tjede; Overvad, Maria; Edslev, Sofie Marie; Fonager, Jannik; Ingham, Anna Cäcilia; Rasmussen, Morten; Madsen, Sarah Leth; Espersen, Caroline Hjorth; Sieber, Raphael N; Stegger, Marc; Gunalan, Vithiagaran; Wilkowski, Bartlomiej; Larsen, Nicolai Balle; Legarth, Rebecca; Cohen, Arieh Sierra; Nielsen, Finn; Lam, Janni Uyen Hoa; Lavik, Kjetil Erdogan; Karakis, Marianne; Spiess, Katja; Marving, Ellinor; Nielsen, Christian; Wiid Svarrer, Christina; Bybjerg-Grauholm, Jonas; Olsen, Stefan Schytte; Jensen, Anders; Krause, Tyra Grove; Müller, Luise.
  • Espenhain L; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Funk T; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Overvad M; European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden.
  • Edslev SM; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Fonager J; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Ingham AC; Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Rasmussen M; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Madsen SL; Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Espersen CH; COVID-19 tracing Unit, Danish Patient Safety Authority, Copenhagen, Denmark.
  • Sieber RN; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Stegger M; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Gunalan V; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Wilkowski B; Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Larsen NB; TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Legarth R; Danish National Biobank, Statens Serum Institut, Copenhagen, Denmark.
  • Cohen AS; TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Nielsen F; Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Lam JUH; TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Lavik KE; The Data integration and Analysis Secretariat, Statens Serum Institut, Copenhagen, Denmark.
  • Karakis M; The Data integration and Analysis Secretariat, Statens Serum Institut, Copenhagen, Denmark.
  • Spiess K; The Data integration and Analysis Secretariat, Statens Serum Institut, Copenhagen, Denmark.
  • Marving E; The Data integration and Analysis Secretariat, Statens Serum Institut, Copenhagen, Denmark.
  • Nielsen C; Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Wiid Svarrer C; Virus and Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
  • Bybjerg-Grauholm J; TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.
  • Olsen SS; Danish National Biobank, Statens Serum Institut, Copenhagen, Denmark.
  • Jensen A; Department of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
  • Krause TG; Congenital disorders, Statens Serum Institut, Copenhagen, Denmark.
  • Müller L; The Data integration and Analysis Secretariat, Statens Serum Institut, Copenhagen, Denmark.
Euro Surveill ; 26(50)2021 12.
Article in English | MEDLINE | ID: covidwho-1593153
ABSTRACT
By 9 December 2021, 785 SARS-CoV-2 Omicron variant cases have been identified in Denmark. Most cases were fully (76%) or booster-vaccinated (7.1%); 34 (4.3%) had a previous SARS-CoV-2 infection. The majority of cases with available information reported symptoms (509/666; 76%) and most were infected in Denmark (588/644; 91%). One in five cases cannot be linked to previous cases, indicating widespread community transmission. Nine cases have been hospitalised, one required intensive care and no deaths have been registered.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.Es.2021.26.50.2101146

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study Topics: Vaccines / Variants Limits: Humans Country/Region as subject: Europa Language: English Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: 1560-7917.Es.2021.26.50.2101146